Maternal Characteristics, Mean Arterial Pressure and Serum Markers in Early Prediction of Preeclampsia

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Kuc, Sylwia ^a   Koster, Maria P H ^a   Franx, Arie ^a   Schielen, Peter C J I ^b   Visser, Gerard H A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ADAM12 PROTEIN; BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY HEIGHT; BODY WEIGHT; CASE CONTROL STUDY; CONTROLLED STUDY; FALSE POSITIVE RESULT; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL BLOOD; MEAN ARTERIAL PRESSURE; NULLIPARA; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANCY OUTCOME; SMALL FOR DATE INFANT; SMOKING;

ADAM PROTEINS; ADULT; ARTERIAL PRESSURE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MEMBRANE PROTEINS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A;

EID: 84878030404     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063546     Document Type: Article

References (33)

1. Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH, (2011) Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn 31: 66-74.
2. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM, (2001) The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 20: 9-14.
3. Kuc S, Wortelboer EJ, van Rijn BB, Franx A, Visser GH, et al. (2011) Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv 66: 225-239.
4. Roberts JM, Pearson GD, Cutler JA, Lindheimer MD, (2003) Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertens Pregnancy 22: 109-127.
5. Sibai B, Dekker G, Kupferminc M, (2005) Pre-eclampsia. Lancet 365: 785-799.
6. Huppertz B, (2008) Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 51: 970-975.
7. Redman CW, Sargent IL, (2005) Latest advances in understanding preeclampsia. Science 308: 1592-1594.
8. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R, (2010) Pre-eclampsia. Lancet 376: 631-644.
9. Bujold E, Morency AM, Roberge S, Lacasse Y, Forest JC, et al. (2009) Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis. J Obstet Gynaecol Can 31: 818-826.
10. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, et al. (2010) Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 116: 402-414.
11. Wortelboer EJ, Koster MP, Cuckle HS, Stoutenbeek PH, Schielen PC, et al. (2010) First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia. BJOG 117: 1384-1389.
12. Foidart JM, Munaut C, Chantraine F, Akolekar R, Nicolaides KH, (2010) Maternal plasma soluble endoglin at 11-13 weeks' gestation in pre-eclampsia. Ultrasound Obstet Gynecol 35: 680-687.
13. Poon LC, Akolekar R, Lachmann R, Beta J, Nicolaides KH, (2010) Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11-13 weeks. Ultrasound Obstet Gynecol 35: 662-670.
14. Robinson HP, Fleming JE, (1975) A critical evaluation of sonar "crown-rump length" measurements. Br J Obstet Gynaecol 82: 702-710.
15. Visser GH, Eilers PH, Elferink-Stinkens PM, Merkus HM, Wit JM, (2009) New Dutch reference curves for birthweight by gestational age. Early Hum Dev 85: 737-744.
16. Cnossen JS, Vollebregt KC, de Vrieze N, ter Riet G, Mol BW, et al. (2008) Accuracy of mean arterial pressure and blood pressure measurements in predicting pre-eclampsia: systematic review and meta-analysis. BMJ 336: 1117-1120.
17. Roberts JM, (1998) Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 16: 5-15.
18. Visser N, van Rijn BB, Rijkers GT, Franx A, Bruinse HW, (2007) Inflammatory changes in preeclampsia: current understanding of the maternal innate and adaptive immune response. Obstet Gynecol Surv 62: 191-201.
19. Taylor RN, Grimwood J, Taylor RS, McMaster MT, Fisher SJ, et al. (2003) Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 188: 177-182.
20. Wortelboer EJ, Koster MP, Kuc S, Eijkemans MJ, Bilardo CM, et al. (2011) Longitudinal trends in fetoplacental biochemical markers, uterine artery pulsatility index and maternal blood pressure during the first trimester of pregnancy. Ultrasound Obstet Gynecol 38: 383-388.
21. Akolekar R, Zaragoza E, Poon LC, Pepes S, Nicolaides KH, (2008) Maternal serum placental growth factor at 11+0 to 13+6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 32: 732-739.
22. Akolekar R, de Cruz J, Foidart JM, Munaut C, Nicolaides KH, (2010) Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia. Prenat Diagn 30: 191-197.
23. Vandenberghe G, Mensink I, Twisk JW, Blankenstein MA, Heijboer AC, et al. (2011) First trimester screening for intra-uterine growth restriction and early-onset pre-eclampsia. Prenat Diagn 31: 955-961.
24. Yu J, Shixia CZ, Wu Y, Duan T, (2011) Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 37: 528-533.
25. Llurba E, Carreras E, Gratacos E, Juan M, Astor J, et al. (2009) Maternal history and uterine artery Doppler in the assessment of risk for development of early- and late-onset preeclampsia and intrauterine growth restriction. Obstet Gynecol Int. doi: 10.1155/2009/275613.
26. Kahn SR, Almeida ND, McNamara H, Koren G, Genest J Jr, et al. (2011) Smoking in preeclamptic women is associated with higher birthweight for gestational age and lower soluble fms-like tyrosine kinase-1 levels: a nested case control study. BMC Pregnancy Childbirth doi: 10.1186/1471-2393-11-91.
27. Lindqvist PG, Marsal K, (1999) Moderate smoking during pregnancy is associated with a reduced risk of preeclampsia. Acta Obstet Gynecol Scand 78: 693-697.
28. North RA, Taylor R, Li Zhou R, Schellenberg JC, (2000) The relationship of smoking, preeclampsia, and secretory component. Am J Obstet Gynecol 183: 136-139.
29. Baschat AA, (2004) Pathophysiology of fetal growth restriction: implications for diagnosis and surveillance. Obstet Gynecol Surv 59: 617-627.
30. Dieber-Rotheneder M, Beganovic S, Desoye G, Lang U, Cervar-Zivkovic M, (2012) Complex expression changes of the placental endothelin system in early and late onset preeclampsia, fetal growth restriction and gestational diabetes. Life Sci 91: 710-715.
31. Roberts JM, Escudero C, (2012) The placenta in preeclampsia. Pregnancy Hypertens 2: 72-83.
32. Roberge S, Giguere Y, Villa P, Nicolaides K, Vainio M, et al. (2012) Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. Am J Perinatol doi: 10.1055/s-0032-1310527.
33. Borzychowski AM, Sargent IL, Redman CW, (2006) Inflammation and pre-eclampsia. Semin Fetal Neonatal Med 11: 309-316.